Facioscapulohumeral Dystrophy clinical trials at UC Irvine

1 in progress, 0 open to eligible people

Showing trials for

  • Del-brax (Also Referred to as AOC 1020) in Participants With FSHD

    Sorry, not currently recruiting here

    A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)

    Orange, California and other locations

Our lead scientists for Facioscapulohumeral Dystrophy research studies include .

Last updated: